Xeomin, lyophilizate 50 units
€221.20 €184.33
-idiopathic cervical dystonia (spastic torticollis) of predominantly rotatory form;
– spasticity of the upper extremity after the stroke in adults;
– spasticity of the upper extremity after stroke in adults. –
– spastic equinus and equinovarus foot deformity in children with cerebral palsy in children from 2 to 18 years old;
– Chronic sialorrhea in adults;
– Chronic sialorrhea in children from 2 to 18 years old;
– Hyperkinetic wrinkles (facial mimicry).
Active ingredient
Composition
How to take, the dosage
Volume of solvent per vial containing 100 units (ml)
./p>
Solvent volume per vial containing 50 units (ml)
Ed/0.1 ml
0.25
0.5
1.0
1.25
2.0
/p>
2.5
4.0
5.0
not applicable
0.125
0.25
0.5
0.625
1.0
1.25
2.0
2.5
4.0
/td>
40
20
10
8
5
4
2.5
p> 2
1.25
Clinical pattern
ED (range)
Number of injection points per muscle
Hand bent at wrist
Multiple hand flexor
10-50
5-30
5-30
1
1
1
Interaction
Special Instructions
Contraindications
Side effects
Indesirable reactions are usually observed in the first week after administration of the drug and are temporary. Unwanted reactions may be related to the active substance and/or to the administration procedure. The expected pharmacological effect of botulinum toxin administration is localized muscle weakness.
The unwanted reactions are classified by frequency of occurrence: very frequently (â¥1/10), frequently (â¥1/100 to < 1/10), infrequently (â¥1/1,000 to â¤1/100), rarely (â¥1/10,000 to â¤1/1,000), very rarely (â¤1/10,000), frequency not determined (cannot be estimated from available data).
Blepharospasm:
Classification of adverse reactions according to organ and organ system involvement (MedDRA)
./p>
Frequency of adverse reaction
Unwanted reaction
Nervous system disorders
Infrequent
Headache
Facial nerve palsy
Visual disturbances
very often
Ptosis of eyelid
Often
Dry eyes Decreased visual clarity
/p>
Visual disturbances
Infrequent
Diplopia
Tearfulness
Gastrointestinal tract disorders
Dyslopia/p>
Often
Dry mouth
Infrequently
Dysphagia
Musculoskeletal and connective tissue disorders
/p>
Infrequent
Muscle weakness
General disorders and disorders at the site of administration
Often
Pain at injection site
injection
Infrequent
Fatigue
Skin and subcutaneous tissue disorders
/p>
Infrequent
Skin rashes
Classification of adverse reactions according to organ and organ system involvement (MedDRA)
The frequency of adverse reactions
Unwanted reaction
Nervous system disorders
Often
Headache
Predizure
Headache
Headache
Infrequent
Speech disorders
Respiratory system, thoracic and mediastinal disorders
Infrequent
Dysphonia
/p>
Shortness of breath
Infectious and parasitic diseases
Often
/p>
Upper respiratory tract infection
Gastrointestinal tract disorders
Infections with gastrointestinal tract/p>
Very often
Dysphagia
often
/p>
Mouth dryness
Nausea
Skin and subcutaneous tissue disorders
/p>
Often
Increased sweating
Infrequent
Skin rashes
Musculoskeletal and connective disorders
/p>
connective tissue
Often
Neck pain
p> Muscle weakness
Myalgia
Muscle stiffness
p> Muscle spasms
General disorders and disorders at the site of administration
Often
Pain at injection site
Asthenia
Classification of adverse reactions according to organ and organ system involvement (MedDRA)
Frequency of adverse reaction
Unwanted reaction
Often
Dry mouth
Infrequent
Dysphagia
Nausea
/p>
Musculoskeletal and connective disorders
/p>
connective tissue
Infrequent
Muscular
weakness
Pain in limb
Myalgia
/p>
General disorders and disorders at the site of administration
/p>
Infrequent
Asthenia
Frequency not established
Pain at injection site
/p>
Classification of adverse reactions according to organ and organ system involvement
(MedDRA)
Frequency of developing an adverse reaction
Unwanted reaction
Infectious and parasitic diseases
Very common
Viral infections of the upper respiratory tract Nasopharyngitis Infectious otitis media
/p>
Nervous system disorders
Often
Somnolence Gait disturbances Paresthesias
Skin and subcutaneous tissue disorders
Often
Skin rashes
Musculoskeletal and connective tissue disorders
Often
Myalgia Muscle weakness
Pain in limb
Infrequent
Myofascial pain syndrome
Renal and urinary tract disorders
Often
Tension urinary incontinence
Injuries, intoxications, and complications of manipulation
/td>
Often
Falls
General disorders and disorders at the injection site
Often
Malaise Pain at the injection site Asthenia
Infrequent
Redness at injection site
Flu-like symptoms
Classification of adverse reactions according to organ and organ system involvement (MedDRA)
The frequency of an adverse reaction
Adverse reaction
Gastrointestinal disorders
Often
Dryness
In the mouth
Dysphagia
Infrequent
changing (thickening) of saliva
/p>
Dysgeusia
Nervous system disorders
Often
Paresthesia
Infrequent
Speech impairment
Classification of adverse reactions according to organ and organ system involvement (MedDRA)
The frequency of adverse reactions
Unwanted reaction
Gastrointestinal disorders
Infrequent
Dryness
In the mouth Dysphagia
Alteration (thickening) of saliva
Classification of adverse reactions according to organ and organ system involvement (MedDRA)
Frequency of adverse reaction
Unwanted reaction
/p>
Nervous system disorders
Very often
Headache
Often
Hypoesthesia
Visual disturbances
/p>
Often
Eyelid edema
/p>
Dry eyes
Ptosis of the eyelid
Infrequent
Decreased visual clarity
Skin and subcutaneous tissue disorders
Often
Brow ptosis
Infrequent
Itching
Musculoskeletal and connective tissue disorders
Often
/p>
Infrequent
Muscle spasms in the brow area
Gastrointestinal disorders
Often
Nausea
General disorders and disorders at the point of administration
Often
bruise at the injection site
Pain at the injection site
Browning at the injection site
Discomfort (heavy feeling in the forehead)
Infrequent
Hemorrhage at the injection site
Hypopod-like symptoms
Local soreness in the area between the eyebrows and in the brow bone area
Tiredness
Discomfort (feeling of heaviness in the eyelid and brow area)
Vascular disorders
Infrequent
Hematoma
Overdose
Pregnancy use
Weight | 0.035 kg |
---|---|
Shelf life | 3 years. Do not use after the expiration date. |
Conditions of storage | At a temperature not higher than 25 ° C. Keep out of reach of children. |
Manufacturer | Merz Pharma GmbH & Co. KGaA, Germany |
Medication form | lyophilizate |
Brand | Merz Pharma GmbH & Co. KGaA |
Related products
Buy Xeomin, lyophilizate 50 units with delivery to USA, UK, Europe and over 120 other countries.